BinaxNOW and NAVICA: TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW and NAVICA: TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW and NAVICA: TAKING COVID-19 TESTING TO A NEW LEVEL BinaxNOW and NAVICA: TAKING COVID-19 TESTING TO A NEW LEVEL

SCALING UP ACCESS TO CORONAVIRUS TESTING

 

In this critical moment in the pandemic, testing is fundamental in our ability to help facilitate a return to work, school and life with a bit more confidence. BinaxNOW is a fast, reliable, affordable and portable rapid test that Abbott will produce at mass scale to greatly expand access to testing to people who need it. We'll ship tens of millions of tests in September, ramping production to 50 million tests a month in October.

 

We're pairing this $5, 15-minute, easy-to-use test with a mobile app, called NAVICA, which works like a secure digital "boarding pass" that can be scanned to enter organizations and other places where people gather. This combination is life-changing technology that will attack the pandemic on critical fronts – speed, simplicity, affordability, access and reliability.


ACCESS THE TEST AND NAVICA APP
SIGN UP

Sign up to be notifiedFor U.S. residents, sign up to get notified when testing is available in your area.

 

 
DOWNLOAD THE APP

Get the app before your first test.

Apple Store

Google Play

FOR PROFESSIONALS

Click here for product information on the BinaxNOW™ COVID-19 Ag Card and the NAVICA App.


THE TECH

THE SCIENCE

Connect with Us
Sign up

The BinaxNOW COVID-19 Ag Card EUA has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

FOR THE LATEST ON LIFE-CHANGING TECHNOLOGY, GET ABBOTT EDGE DELIVERED TO YOUR INBOX

Please Enter Your Email

*Required 

Intended for U.S. residents only. Please review our privacy policy and terms & conditions.

true
accessibility

You are about to exit for another Abbott country or region specific website

Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.


The website you have requested also may not be optimized for your specific screen size.

Do you wish to continue and exit this website?

accessibility

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.


The website that you have requested also may not be optimized for your screen size.

Do you wish to continue and exit this website?